- Home
- MOLN vs FCAP Comparison
MOLN vs FCAP Comparison
Compare MOLN & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- FCAP
- Stock Information
- Founded
- MOLN 2004
- FCAP 1891
- Country
- MOLN Switzerland
- FCAP United States
- Employees
- MOLN N/A
- FCAP N/A
- Industry
- MOLN
- FCAP Savings Institutions
- Sector
- MOLN
- FCAP Finance
- Exchange
- MOLN Nasdaq
- FCAP Nasdaq
- Market Cap
- MOLN 142.6M
- FCAP 125.9M
- IPO Year
- MOLN 2021
- FCAP 1999
- Fundamental
- Price
- MOLN $3.72
- FCAP $43.45
- Analyst Decision
- MOLN Hold
- FCAP
- Analyst Count
- MOLN 1
- FCAP 0
- Target Price
- MOLN $4.00
- FCAP N/A
- AVG Volume (30 Days)
- MOLN 5.2K
- FCAP 4.0K
- Earning Date
- MOLN 11-05-2025
- FCAP 10-24-2025
- Dividend Yield
- MOLN N/A
- FCAP 2.67%
- EPS Growth
- MOLN N/A
- FCAP 9.31
- EPS
- MOLN N/A
- FCAP 3.93
- Revenue
- MOLN $856,302.00
- FCAP $44,673,000.00
- Revenue This Year
- MOLN N/A
- FCAP N/A
- Revenue Next Year
- MOLN $1,000.00
- FCAP N/A
- P/E Ratio
- MOLN N/A
- FCAP $11.06
- Revenue Growth
- MOLN N/A
- FCAP 9.48
- 52 Week Low
- MOLN $3.36
- FCAP $28.50
- 52 Week High
- MOLN $7.60
- FCAP $53.85
- Technical
- Relative Strength Index (RSI)
- MOLN 50.93
- FCAP 65.26
- Support Level
- MOLN $3.69
- FCAP $42.77
- Resistance Level
- MOLN $3.85
- FCAP $44.04
- Average True Range (ATR)
- MOLN 0.21
- FCAP 0.83
- MACD
- MOLN 0.01
- FCAP 0.39
- Stochastic Oscillator
- MOLN 14.29
- FCAP 91.01
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.